The emerging clinical arena is hybrid sequences. These engineered molecules combine segments derived from multiple peptide origins, enabling the development of novel biological properties. This strategy presents a https://chimerapeptides447796.wikicommunications.com/8340440/chimera_peptides_a_novel_therapeutic_frontier